$THRY
Thryv Holdings Inc Stock $thry

$thry Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000162828021005660 Filed on March 25, 2021

Income Statement

Concept	2020 Q4	2020	2019 Q4
Revenue	$1.784B	$1.109B
YoY Change		-21.95%
Cost Of Revenue	$87.80M	$439.7M
YoY Change		-24.35%
Gross Profit	$159.2M	$669.7M
YoY Change		-20.28%
Gross Profit Margin	8.92%	60.36%
Selling, General & Admin	$99.50M	$492.8M
YoY Change		-21.58%
% of Gross Profit	62.5%	73.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$35.60M	$146.5M	$101.5M
YoY Change	-64.93%	-28.97%
% of Gross Profit	22.36%	21.88%
Operating Expenses	$135.1M	$492.8M
YoY Change		-21.58%
Operating Profit	$24.10M	$152.0M
YoY Change		-26.23%
Interest Expense	-$15.00M	$68.54M
YoY Change		-26.26%
% of Operating Profit	-62.24%	45.09%
Other Income/Expense, Net	-$10.90M	$3.614M
YoY Change		-166.53%
Pretax Income	-$8.500M	$41.24M
YoY Change		-23.01%
Income Tax	-$118.3M	-$108.0M
% Of Pretax Income		-261.85%
Net Earnings	$109.8M	$149.2M
YoY Change		320.29%
Net Earnings / Revenue	6.15%	13.45%
Basic Earnings Per Share		$4.73
Diluted Earnings Per Share	$3.307M	$4.42
COMMON SHARES
Basic Shares Outstanding	31.03M shares	31.52M shares
Diluted Shares Outstanding		33.80M shares

Balance Sheet

Concept	2020 Q4	2020	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.400M	$2.400M
YoY Change		26.32%
Cash & Equivalents	$2.406M	$2.400M	$1.912M
Short-Term Investments
Other Short-Term Assets	$12.76M	$50.50M
YoY Change		-12.63%
Inventory
Prepaid Expenses
Receivables	$296.6M	$307.5M	$369.7M
Other Receivables	$9.300M	$9.300M
Total Short-Term Assets	$369.7M	$369.7M	$478.6M
YoY Change	-22.75%	-22.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$89.04M	$89.00M	$101.5M
YoY Change	-12.28%	-36.7%
Goodwill	$609.5M		$609.5M
YoY Change	0.0%		0.0%
Intangibles	$31.78M		$147.5M
YoY Change	-78.45%
Long-Term Investments
YoY Change
Other Assets	$21.90M	$115.0M	$51.27M
YoY Change	-57.28%	842.62%
Total Long-Term Assets	$845.3M	$845.3M	$909.7M
YoY Change	-7.08%	-7.08%
TOTAL ASSETS
Total Short-Term Assets	$369.7M	$369.7M	$478.6M
Total Long-Term Assets	$845.3M	$845.3M	$909.7M
Total Assets	$1.215B	$1.215B	$1.388B
YoY Change	-12.48%	-12.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.927M	$8.900M	$16.07M
YoY Change	-44.44%	-44.72%
Accrued Expenses	$139.6M	$139.6M	$140.3M
YoY Change	-0.46%	-14.36%
Deferred Revenue	$18.94M		$24.68M
YoY Change	-23.25%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$207.4M	$207.4M	$257.4M
YoY Change	-19.44%	-19.43%
LONG-TERM LIABILITIES
Long-Term Debt	$528.4M	$583.2M
YoY Change		-24.25%
Other Long-Term Liabilities	$36.27M	$227.1M	$85.39M
YoY Change	-57.53%	-18.57%
Total Long-Term Liabilities	$810.8M	$810.3M	$1.104B
YoY Change	-26.53%	-22.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$207.4M	$207.4M	$257.4M
Total Long-Term Liabilities	$810.8M	$810.3M	$1.104B
Total Liabilities	$1.018B	$1.018B	$1.361B
YoY Change	-25.19%	-25.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$394.8M		-$544.1M
YoY Change	-27.43%
Common Stock	$596.0K		$574.0K
YoY Change	3.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$468.6M		$438.0M
YoY Change	7.0%
Treasury Stock Shares	26.68M shares		23.95M shares
Shareholders Equity	$196.8M	$196.8M	$27.26M
YoY Change
Total Liabilities & Shareholders Equity	$1.215B	$1.215B	$1.388B
YoY Change	-12.48%	-12.48%

Cashflow Statement

Concept	2020 Q4	2020	2019 Q4
OPERATING ACTIVITIES
Net Income	$109.8M	$149.2M
YoY Change		320.29%
Depreciation, Depletion And Amortization	$35.60M	$146.5M	$101.5M
YoY Change	-64.93%	-28.97%
Cash From Operating Activities	$58.20M	$232.8M	$147.1M
YoY Change	-60.44%	-13.98%
INVESTING ACTIVITIES
Capital Expenditures	-$10.80M	-$27.80M	-$20.10M
YoY Change	-46.27%	6.51%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$10.70M	-$26.21M	-$20.10M
YoY Change	-46.77%	3.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$30.63M
YoY Change		-93.01%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-46.90M	-$206.1M	-131.0M
YoY Change	-64.2%	-25.74%
NET CHANGE
Cash From Operating Activities	58.20M	$232.8M	147.1M
Cash From Investing Activities	-10.70M	-$26.21M	-20.10M
Cash From Financing Activities	-46.90M	-$206.1M	-131.0M
Net Change In Cash	600.0K	$494.0K	-4.000M
YoY Change	-115.0%	-101.53%
FREE CASH FLOW
Cash From Operating Activities	$58.20M	$232.8M	$147.1M
Capital Expenditures	-$10.80M	-$27.80M	-$20.10M
Free Cash Flow	$69.00M	$260.6M	$167.2M
YoY Change	-58.73%	-12.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001556739
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2017	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201409Member
CY2018	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201602Member
CY2020Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.5555
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2019Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2020Q4	us-gaap	Defined Benefit Plan Type Extensible List DefinedBenefitPlanTypeExtensibleList	us-gaap:PensionPlansDefinedBenefitMember
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-35895
CY2020	dei	Entity Registrant Name EntityRegistrantName	THRYV HOLDINGS, INC.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-2740040
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	2200 West Airfield Drive, P.O. Box 619810
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	D/FW Airport
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75261
CY2020	dei	City Area Code CityAreaCode	(972)
CY2020	dei	Local Phone Number LocalPhoneNumber	453-7000
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2020	dei	Trading Symbol TradingSymbol	THRY
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Public Float EntityPublicFloat	0	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33127667	shares
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1109435000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1421374000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1784401000	USD
CY2020	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	366696000	USD
CY2019	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	476355000	USD
CY2018	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	647288000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	263006000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	352740000	USD
CY2018	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	469238000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	156286000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	174286000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	238554000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	146523000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	206270000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	266975000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	24911000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5670000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	957422000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	1215321000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	1622055000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	152013000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	206053000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	162346000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	51537000	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	68181000	USD
CY2018	us-gaap	Interest Expense Debt InterestExpenseDebt	53851000	USD
CY2020	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	17002000	USD
CY2019	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	24770000	USD
CY2018	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	28846000	USD
CY2020	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	42236000	USD
CY2019	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	53161000	USD
CY2018	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	516000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-6375000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18375000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	41238000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	53566000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	60758000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-107983000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18062000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8487000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	149221000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	35504000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	52271000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.73
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.87
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.42
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.82
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31522845	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40845128	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57331622	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33795594	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43465998	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59631195	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2406000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1912000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	33030000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	26828000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	296570000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	369690000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	338000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	0	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	10975000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	11682000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	9229000	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	37460000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26172000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28036000	USD
CY2020Q4	dxm	Indemnification Asset Current IndemnificationAssetCurrent	24346000	USD
CY2019Q4	dxm	Indemnification Asset Current IndemnificationAssetCurrent	29789000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	369698000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	478569000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	89044000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101512000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	609457000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	609457000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	31777000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	147480000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	93099000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21902000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51274000	USD
CY2020Q4	us-gaap	Assets Assets	1214977000	USD
CY2019Q4	us-gaap	Assets Assets	1388292000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8927000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16067000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	139613000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	140261000	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	30022000	USD
CY2019Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	53111000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18942000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	24679000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9896000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	23323000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	207400000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	257441000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	445000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	593000	USD
CY2020Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	335683000	USD
CY2019Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	420036000	USD
CY2020Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	113482000	USD
CY2019Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	189371000	USD
CY2020Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	79238000	USD
CY2019Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	104985000	USD
CY2020Q4	dxm	Financing Obligations Noncurrent FinancingObligationsNoncurrent	54798000	USD
CY2019Q4	dxm	Financing Obligations Noncurrent FinancingObligationsNoncurrent	55537000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	190827000	USD
CY2019Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	193533000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	508000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	54738000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	36266000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	85391000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	810802000	USD
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1103591000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59590422	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32912012	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57443282	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33490526	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	596000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	574000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1059624000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1008701000	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	26678410	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	23952756	shares
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	468613000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	437962000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-394832000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-544053000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	196775000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	27260000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1214977000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1388292000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	213556000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	52271000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	428340000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	437962000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1880000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	35504000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	27260000	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	30626000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12815000	USD
CY2020	dxm	Adjustments To Additional Paid In Capital Reclassification Of Stock Options AdjustmentsToAdditionalPaidInCapitalReclassificationOfStockOptions	37661000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	444000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	149221000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	196775000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	149221000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	35504000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	52271000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	146523000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	206270000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	266975000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1068000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1123000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1576000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-147329000	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-25118000	USD
CY2018	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-22745000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	32077000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	30092000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24214000	USD
CY2020	dxm	Provision For Service Credits ProvisionForServiceCredits	32550000	USD
CY2019	dxm	Provision For Service Credits ProvisionForServiceCredits	25467000	USD
CY2018	dxm	Provision For Service Credits ProvisionForServiceCredits	31491000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	-2895000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	14119000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	39604000	USD
CY2020	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	42236000	USD
CY2019	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	53161000	USD
CY2018	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	516000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-6375000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18375000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3544000	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5942000	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-11464000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	24911000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5670000	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	dxm	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	-5443000	USD
CY2019	dxm	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	-4093000	USD
CY2018	dxm	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	9518000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-41382000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-16457000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14456000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-369000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-1515000	USD
CY2018	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	4834000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-472000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5676000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3019000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-100708000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-69244000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-72112000	USD
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	14547000	USD
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4376000	USD
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-12797000	USD
CY2020	dxm	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-4006000	USD
CY2019	dxm	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-10587000	USD
CY2018	dxm	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	0	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-5737000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6391000	USD
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	11144000	USD
CY2020	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-896000	USD
CY2019	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-33901000	USD
CY2018	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	232772000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	270599000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	347061000	USD
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	27757000	USD
CY2019	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	26065000	USD
CY2018	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	27429000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1546000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	847000	USD
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	17000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	147000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1250000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26211000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25365000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28662000	USD
CY2020	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	113747000	USD
CY2019	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	148256000	USD
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	46643000	USD
CY2019	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	66744000	USD
CY2020	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	193625000	USD
CY2018	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	381625000	USD
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2019	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	225000000	USD
CY2018	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2018	dxm	Repayments Of Long Term Lines Of Credit Extinguishment RepaymentsOfLongTermLinesOfCreditExtinguishment	198973000	USD
CY2018	dxm	Repayments Of Long Term Lines Of Credit Extinguishment Related Party RepaymentsOfLongTermLinesOfCreditExtinguishmentRelatedParty	155368000	USD
CY2018	dxm	Repayments Of Long Term Lines Of Credit Before Extinguishment RepaymentsOfLongTermLinesOfCreditBeforeExtinguishment	166774000	USD
CY2018	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	130226000	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1143700000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1142717000	USD
CY2018	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1823207000	USD
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1169446000	USD
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1184310000	USD
CY2018	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1836642000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	30626000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	437962000	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	10695000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1561000	USD
CY2018	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3117000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-206067000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-277491000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-286268000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	494000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-32257000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	32131000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1912000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34169000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2038000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2406000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1912000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34169000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	72931000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	81543000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	80972000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	24799000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	38091000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	44029000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements requires management to make estimates and assumptions about future events that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. The results of those estimates form the basis for making judgments about the carrying values of certain assets and liabilities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of reported amounts that rely on significant estimates include revenue recognition, allowance for credit losses, capitalized costs to obtain a contract, certain amounts relating to the accounting for income taxes, including net valuation allowance, indemnification asset, stock-based compensation expense, operating lease right-of-use assets and operating lease liabilities, accrued service credits, and net pension obligation. Significant estimates are also used in determining the recoverability and fair value of fixed assets and capitalized software, operating lease right-of-use assets, goodwill, and intangible assets.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the novel strain of coronavirus, commonly referred to as COVID-19 (“</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”) and the uncertainty of the extent of the impacts related thereto, certain estimates and assumptions may require increased judgment. As events continue to evolve and additional information becomes available, these estimates may change in future periods. It is difficult to predict what the ongoing impact of the pandemic will be on future periods.</span></div>
CY2020Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	9100000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	2800000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	13600000	USD
CY2019Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	10500000	USD
CY2019Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	3100000	USD
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	14100000	USD
CY2018Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	10300000	USD
CY2018Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	3500000	USD
CY2018	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	9900000	USD
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	329938000	USD
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	396518000	USD
CY2020Q4	dxm	Accounts Receivable And Receivables From Contract With Customer Allowance For Credit Loss Current AccountsReceivableAndReceivablesFromContractWithCustomerAllowanceForCreditLossCurrent	33368000	USD
CY2019Q4	dxm	Accounts Receivable And Receivables From Contract With Customer Allowance For Credit Loss Current AccountsReceivableAndReceivablesFromContractWithCustomerAllowanceForCreditLossCurrent	26828000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	296570000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	369690000	USD
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments subject to concentrations of credit risk consist primarily of trade receivables. The Company deposits cash on hand with major financial institutions. Cash balances at major financial institutions may exceed limits insured by the Federal Deposit Insurance Corporation.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of revenue in all periods presented was derived from sales to local SMBs that operate in limited geographical areas. These SMBs are usually billed in monthly installments when the services begin and, in turn, make monthly payments, requiring the Company to extend credit to these clients. This practice is widely accepted within the industry. While most new SMBs and those wanting to expand their current media presence through the Company’s services are subject to a credit review, the default rates of SMBs are generally higher than those of larger companies. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining approximate </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of revenue in all periods presented was derived from the sale of marketing services to larger businesses that advertise regionally or nationally. Contracted certified marketing representatives (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CMRs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”) purchase advertising on behalf of these businesses. Payment for advertising is due when the advertising is published and is received directly from the CMRs, net of the CMRs’ commission. The CMRs are responsible for billing and collecting from these businesses. While the Company still has exposure to credit risks, historically, the losses from this client set have been less than that of local SMBs.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its operations in the United States of America. In 2020, the Company's top ten directories, as measured by revenue, accounted for approximately 2% of total revenue. No single directory or client accounted for more than 1% of the Company’s revenue for the years ended December 31, 2020, 2019 and 2018. Additionally, no single client or CMR accounted for more than 5% of the Company’s outstanding accounts receivable as of December 31, 2020 and December 31, 2019.</span></div>
CY2020	us-gaap	Advertising Expense AdvertisingExpense	7200000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	5500000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	23400000	USD
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59590422	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32912012	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57443282	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33490526	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	26678410	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	23952756	shares
CY2020	us-gaap	Deferred Compensation Arrangement With Individual Requisite Service Period1 DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1	P3Y
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	24700000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	31100000	USD
CY2018	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	19900000	USD
CY2020	dxm	Revenue From Contract With Customer Excluding Assessed Tax Covid19 Credits RevenueFromContractWithCustomerExcludingAssessedTaxCOVID19Credits	17500000	USD
CY2020	dxm	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	-5400000	USD
CY2019	dxm	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	-4100000	USD
CY2019Q4	dxm	Deferred Compensation And Unrecognized Share Based Arrangements Liability Fair Value Disclosure DeferredCompensationAndUnrecognizedShareBasedArrangementsLiabilityFairValueDisclosure	60200000	USD
CY2019Q4	us-gaap	Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent	43000000.0	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	37700000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-2900000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14100000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	609500000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	609500000	USD
CY2019Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	712800000	USD
CY2020Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	712800000	USD
CY2020Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	44000000.0	USD
CY2019Q2	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingUnit
CY2019Q3	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	reportingUnit
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018Q4	us-gaap	Goodwill Goodwill	609457000	USD
CY2019	us-gaap	Goodwill Transfers GoodwillTransfers	609457000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	609457000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	609457000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31800000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	147500000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	923199000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	891422000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31777000	USD
CY2020	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P2Y
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	923290000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	775810000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	147480000	USD
CY2019	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P1Y8M12D
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	147480000	USD
CY2020	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	192000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	115613000	USD
CY2020	dxm	Finite Lived Intangible Assets Other Increase Decrease Adjustments FiniteLivedIntangibleAssetsOtherIncreaseDecreaseAdjustments	282000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31777000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	312242000	USD
CY2019	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	1588000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	166350000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	147480000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	115600000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	166400000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	220900000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	16915000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14814000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	48000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31777000	USD
CY2019Q4	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	198900000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	46000000.0	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	87300000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	45960000	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	87307000	USD
CY2019Q4	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	198912000	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	15004000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2020	us-gaap	Payments For Restructuring PaymentsForRestructuring	12933000	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	2071000	USD
CY2019Q4	dxm	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	26828000	USD
CY2018Q4	dxm	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	22571000	USD
CY2017Q4	dxm	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	31193000	USD
CY2020	dxm	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	32077000	USD
CY2019	dxm	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	30092000	USD
CY2018	dxm	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	24214000	USD
CY2020	dxm	Accounts Receivable And Contract With Customer Allowance For Credit Loss Writeoff AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteoff	25537000	USD
CY2019	dxm	Accounts Receivable And Contract With Customer Allowance For Credit Loss Writeoff AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteoff	25835000	USD
CY2018	dxm	Accounts Receivable And Contract With Customer Allowance For Credit Loss Writeoff AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteoff	25707000	USD
CY2020Q4	dxm	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	33368000	USD
CY2019Q4	dxm	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	26828000	USD
CY2018Q4	dxm	Accounts Receivable And Contract With Customer Allowance For Credit Loss AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss	22571000	USD
CY2020	dxm	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	32100000	USD
CY2019	dxm	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	30100000	USD
CY2018	dxm	Accounts Receivable And Contract With Customer Credit Loss Expense Reversal AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal	24200000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	33000000.0	USD
CY2020Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	300000	USD
CY2020	dxm	Accounts Receivable Allowance For Credit Loss Incremental Increase Decrease Due To Covid19 AccountsReceivableAllowanceForCreditLossIncrementalIncreaseDecreaseDueToCOVID19	2100000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	167355000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	181354000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	78311000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79842000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	89044000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101512000	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20718000	USD
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	25913000	USD
CY2018	us-gaap	Adjustment For Amortization AdjustmentForAmortization	29584000	USD
CY2020	us-gaap	Depreciation Nonproduction DepreciationNonproduction	10192000	USD
CY2019	us-gaap	Depreciation Nonproduction DepreciationNonproduction	14007000	USD
CY2018	us-gaap	Depreciation Nonproduction DepreciationNonproduction	16537000	USD
CY2020	us-gaap	Depreciation Depreciation	30910000	USD
CY2019	us-gaap	Depreciation Depreciation	39920000	USD
CY2018	us-gaap	Depreciation Depreciation	46121000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	53844000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	43155000	USD
CY2020Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	2280000	USD
CY2019Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3377000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	26209000	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	27232000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	51284000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	57474000	USD
CY2020Q4	dxm	Accrued Service Credits Current AccruedServiceCreditsCurrent	5996000	USD
CY2019Q4	dxm	Accrued Service Credits Current AccruedServiceCreditsCurrent	9023000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	139613000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	140261000	USD
CY2020	us-gaap	Severance Costs1 SeveranceCosts1	11700000	USD
CY2020	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	20700000	USD
CY2019	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	5700000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	8018000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	12484000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	53000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1144000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	366000	USD
CY2019	us-gaap	Sublease Income SubleaseIncome	680000	USD
CY2020	us-gaap	Lease Cost LeaseCost	7705000	USD
CY2019	us-gaap	Lease Cost LeaseCost	12948000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9202000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39046000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	646000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9579000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24552000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	28783000	USD
CY2020	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1	-819000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	25198000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	38362000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	8713000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	16733000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1423000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	54667000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M6D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M24D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.091
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.090
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3086000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7609000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7546000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6949000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6901000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	32091000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6893000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	25198000	USD
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	16200000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	528403000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	714392000	USD
CY2020Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	2500000	USD
CY2019Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	3500000	USD
CY2019Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	225000000	USD
CY2020Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	200000000	USD
CY2020Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	175000000	USD
CY2020Q4	dxm	Financing Obligations Noncash Residual Value Of Failed Sale Leaseback Transaction FinancingObligationsNoncashResidualValueOfFailedSaleLeasebackTransaction	54676000	USD
CY2019Q4	dxm	Financing Obligations Noncash Residual Value Of Failed Sale Leaseback Transaction FinancingObligationsNoncashResidualValueOfFailedSaleLeasebackTransaction	54676000	USD
CY2020Q4	dxm	Financing Obligations Minimum Lease Payments Failed Sale Leaseback Transaction FinancingObligationsMinimumLeasePaymentsFailedSaleLeasebackTransaction	862000	USD
CY2019Q4	dxm	Financing Obligations Minimum Lease Payments Failed Sale Leaseback Transaction FinancingObligationsMinimumLeasePaymentsFailedSaleLeasebackTransaction	1441000	USD
CY2020Q4	dxm	Financing Obligations FinancingObligations	55538000	USD
CY2019Q4	dxm	Financing Obligations FinancingObligations	56117000	USD
CY2020Q4	dxm	Long Term Debt And Financing Obligations Maturity Year One LongTermDebtAndFinancingObligationsMaturityYearOne	740000	USD
CY2020Q4	dxm	Long Term Debt And Financing Obligations Maturity Year Two LongTermDebtAndFinancingObligationsMaturityYearTwo	122000	USD
CY2020Q4	dxm	Long Term Debt And Financing Obligations Maturity Year Three LongTermDebtAndFinancingObligationsMaturityYearThree	528403000	USD
CY2020Q4	dxm	Long Term Debt And Financing Obligations LongTermDebtAndFinancingObligations	529265000	USD
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	13949000	USD
CY2019	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	22146000	USD
CY2018	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	20946000	USD
CY2020	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	16027000	USD
CY2019	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	15044000	USD
CY2018	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	16716000	USD
CY2019	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1	-693000	USD
CY2018	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1	204000	USD
CY2020	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-43495000	USD
CY2019	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-45366000	USD
CY2018	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	3510000	USD
CY2020	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	42236000	USD
CY2019	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	53161000	USD
CY2018	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	516000	USD
CY2020Q4	dxm	Defined Benefit Plan Number Of Plans Transferred DefinedBenefitPlanNumberOfPlansTransferred	2	plan
CY2020Q4	dxm	Defined Benefit Plan Plan Assets Annuity Purchase DefinedBenefitPlanPlanAssetsAnnuityPurchase	17800000	USD
CY2020	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1	-800000	USD
CY2019	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1	-700000	USD
CY2018	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1	200000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	192269000	USD
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0316
CY2019	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0430
CY2018	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0363
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate	0.0274
CY2019	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate	0.0393
CY2018	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate	0.0323
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0373
CY2019	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0368
CY2018	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0358
CY2020Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0239
CY2019Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0316
CY2020Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate	0.0300
CY2019Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate	0.0336
CY2019Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	643961000	USD
CY2018Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	597077000	USD
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	13949000	USD
CY2019	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	22146000	USD
CY2020	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-63164000	USD
CY2019	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-76161000	USD
CY2020	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	66746000	USD
CY2019	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	51423000	USD
CY2020	dxm	Defined Benefit Plan Benefit Obligation Annuity Purchase DefinedBenefitPlanBenefitObligationAnnuityPurchase	17831000	USD
CY2019	dxm	Defined Benefit Plan Benefit Obligation Annuity Purchase DefinedBenefitPlanBenefitObligationAnnuityPurchase	0	USD
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	636497000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	643961000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	449019000	USD
CY2018Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	424927000	USD
CY2020	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	44908000	USD
CY2019	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	30369000	USD
CY2020	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	34878000	USD
CY2019	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	45146000	USD
CY2020	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	66746000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.20
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	51423000	USD
CY2020	dxm	Defined Benefit Plan Plan Assets Annuity Purchase DefinedBenefitPlanPlanAssetsAnnuityPurchase	17831000	USD
CY2019	dxm	Defined Benefit Plan Plan Assets Annuity Purchase DefinedBenefitPlanPlanAssetsAnnuityPurchase	0	USD
CY2020Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	444228000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	449019000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-192269000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-194942000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	636500000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	644000000.0	USD
CY2020	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements And Curtailments1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1	-44300000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Current DefinedBenefitPensionPlanLiabilitiesCurrent	1442000	USD
CY2019Q4	us-gaap	Defined Benefit Pension Plan Liabilities Current DefinedBenefitPensionPlanLiabilitiesCurrent	1409000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	190827000	USD
CY2019Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	193533000	USD
CY2019	dxm	Adjustments For Acquisition Accounting Fresh Start Accounting And Accounting Conformity AdjustmentsForAcquisitionAccountingFreshStartAccountingAndAccountingConformity	0	USD
CY2018	dxm	Adjustments For Acquisition Accounting Fresh Start Accounting And Accounting Conformity AdjustmentsForAcquisitionAccountingFreshStartAccountingAndAccountingConformity	28587000	USD
CY2019Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	194942000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Accumulated Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsAccumulatedBenefitObligation	636497000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Accumulated Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsAccumulatedBenefitObligation	643961000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation	636497000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation	643961000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	444228000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	449019000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	55025000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	45097000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	43085000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	40822000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	39675000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	169606000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	444228000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	449019000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1.000
CY2019Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1.000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3000000.0	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	10800000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	12600000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	388292	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	482000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.82
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.35
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2549556	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5556	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.20
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.97
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.24
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.43
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5875829	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.29
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M24D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	42433615	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	872003	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.90
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P9Y10M13D
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue	1393499	USD
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cash ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCash	130017	shares
CY2020	dxm	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Cash Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashWeightedAverageExercisePrice	3.68
CY2020Q4	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue	9151100	USD
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cash Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCashWeightedAverageRemainingContractualTerm	P5Y8M26D
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cash Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCashIntrinsicValue	896335	USD
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodShares	2143317	shares
CY2020	dxm	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Shares Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodSharesWeightedAverageExercisePrice	3.69
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Shares Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodSharesWeightedAverageRemainingContractualTerm	P5Y9M7D
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Shares Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodSharesIntrinsicValue	15510765	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	196338	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.22
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsWeightedAverageRemainingContractualTerm	P8Y7M20D
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue	-146415	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4278160	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.20
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M9D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9855005	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	992061	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.28
CY2020	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P5Y9M21D
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	15500000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6069907	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.87
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M14D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	90463239	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2555109	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.20
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P9Y10M17D
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue	0	USD
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cash ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCash	2326019	shares
CY2019	dxm	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Cash Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashWeightedAverageExercisePrice	3.69
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cash Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCashWeightedAverageRemainingContractualTerm	P6Y9M
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cash Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCashIntrinsicValue	33901447	USD
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodShares	111660	shares
CY2019	dxm	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Shares Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodSharesWeightedAverageExercisePrice	3.92
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Shares Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodSharesWeightedAverageRemainingContractualTerm	P6Y9M10D
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Shares Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodSharesIntrinsicValue	1420239	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	311508	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.18
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsWeightedAverageRemainingContractualTerm	P6Y9M21D
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue	3745889	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5875829	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.29
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M24D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	42433615	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2341193	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.80
CY2019	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P6Y9M10D
CY2019Q4	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue	29029972	USD
CY2019Q4	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingFairValue	60200000	USD
CY2019Q4	dxm	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Outstanding Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndOutstandingFairValue	43000000.0	USD
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	17200000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11200000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	400000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	1700000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	400000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-2895000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14119000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39604000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3600000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	10000000.0	USD
CY2020Q3	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	800000	USD
CY2020Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1000000.0	shares
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	12600000	USD
CY2020Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	800000	shares
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9200000	USD
CY2020Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	800000	shares
CY2020Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	8800000	USD
CY2019Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	24000000.0	shares
CY2019Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	438000000.0	USD
CY2019Q2	dxm	Payments Of Capital Distribution To Option Holders PaymentsOfCapitalDistributionToOptionHolders	33900000	USD
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10500000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10500000	USD
CY2019Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5800000	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5800000	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	24.39
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	24.39
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	149221000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	35504000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	52271000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31522845	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40845128	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57331622	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.73
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.87
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	149221000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	35504000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	52271000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31522845	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40845128	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57331622	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2272749	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2620870	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2299573	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33795594	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43465998	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59631195	shares
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.42
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.82
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	30277000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	37319000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	23848000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7213000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5861000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7384000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	37490000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	43180000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	31232000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-101613000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-32327000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7474000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-43860000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	7209000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-15271000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-145473000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-25118000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-22745000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-107983000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18062000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8487000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.074
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.027
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.067
CY2020	dxm	Effective Income Tax Rate Reconciliation Change In Fair Value Of Indemnification Asset EffectiveIncomeTaxRateReconciliationChangeInFairValueOfIndemnificationAsset	0.028
CY2019	dxm	Effective Income Tax Rate Reconciliation Change In Fair Value Of Indemnification Asset EffectiveIncomeTaxRateReconciliationChangeInFairValueOfIndemnificationAsset	0.016
CY2018	dxm	Effective Income Tax Rate Reconciliation Change In Fair Value Of Indemnification Asset EffectiveIncomeTaxRateReconciliationChangeInFairValueOfIndemnificationAsset	-0.033
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.035
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.044
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2020	dxm	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent	0.049
CY2019	dxm	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent	0.008
CY2018	dxm	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2.560
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.019
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.021
CY2020	dxm	Effective Income Tax Rate Reconciliation Change In Unrecognized Tax Benefits Percent EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsPercent	-0.487
CY2019	dxm	Effective Income Tax Rate Reconciliation Change In Unrecognized Tax Benefits Percent EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsPercent	0.053
CY2018	dxm	Effective Income Tax Rate Reconciliation Change In Unrecognized Tax Benefits Percent EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsPercent	0.027
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.003
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.004
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.024
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-2.610
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.337
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.140
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	9979000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	9098000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	10636000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	18165000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	3790000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	3780000	USD
CY2020Q4	dxm	Deferred Tax Assets Debt Capitalized Fees And Other Interest DeferredTaxAssetsDebtCapitalizedFeesAndOtherInterest	2291000	USD
CY2019Q4	dxm	Deferred Tax Assets Debt Capitalized Fees And Other Interest DeferredTaxAssetsDebtCapitalizedFeesAndOtherInterest	4644000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	51231000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	52219000	USD
CY2020Q4	dxm	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	7539000	USD
CY2019Q4	dxm	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	9736000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges	7053000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges	1875000	USD
CY2020Q4	dxm	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	28611000	USD
CY2019Q4	dxm	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	27019000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	420000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	130000	USD
CY2020Q4	dxm	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	46213000	USD
CY2019Q4	dxm	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	30250000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	8335000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8566000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	11239000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	184664000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	168155000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24307000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	126321000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	160357000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	41834000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1658000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	46501000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	71943000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	3003000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	3453000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	5466000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	4676000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	9362000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	10643000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3434000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	4199000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	67766000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	96572000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	92591000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	54738000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	24300000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	126321000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	127294000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	136766000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-102014000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-973000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-5107000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24307000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	126321000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	127294000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	48305000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	48469000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	49521000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	146000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	550000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	22186000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	665000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2416000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	164000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	311000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	772000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	23703000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	48305000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	48469000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-24600000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-200000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1100000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	23700000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	48300000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	48500000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-2300000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	3700000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	2300000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	8400000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	10700000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	7000000.0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	23700000	USD
CY2020Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	21800000	USD
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1109435000	USD
CY2020	dxm	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	371839000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1421374000	USD
CY2019	dxm	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	481099000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1784401000	USD
CY2018	dxm	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	586505000	USD
CY2020	dxm	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	371839000	USD
CY2019	dxm	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	481099000	USD
CY2018	dxm	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	586505000	USD
CY2020	us-gaap	Interest Expense InterestExpense	68539000	USD
CY2019	us-gaap	Interest Expense InterestExpense	92951000	USD
CY2018	us-gaap	Interest Expense InterestExpense	82697000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	146523000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	206270000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	266975000	USD
CY2020	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	42236000	USD
CY2019	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	53161000	USD
CY2018	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	516000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-6375000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18375000	USD
CY2020	dxm	Adjustments For Acquisition Accounting Fresh Start Accounting And Accounting Conformity AdjustmentsForAcquisitionAccountingFreshStartAccountingAndAccountingConformity	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	24911000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5670000	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	dxm	Restructuring Charges And Integration Expenses RestructuringChargesAndIntegrationExpenses	28459000	USD
CY2019	dxm	Restructuring Charges And Integration Expenses RestructuringChargesAndIntegrationExpenses	40290000	USD
CY2018	dxm	Restructuring Charges And Integration Expenses RestructuringChargesAndIntegrationExpenses	87307000	USD
CY2020	dxm	Transaction Costs TransactionCosts	20999000	USD
CY2019	dxm	Transaction Costs TransactionCosts	6081000	USD
CY2018	dxm	Transaction Costs TransactionCosts	0	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-2895000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14119000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39604000	USD
CY2020	dxm	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	-5443000	USD
CY2019	dxm	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	-4093000	USD
CY2018	dxm	Gain Loss On Remeasurement Of Indemnification Asset GainLossOnRemeasurementOfIndemnificationAsset	9518000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3614000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	943000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10991000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	41238000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	53566000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	60758000	USD
CY2020	us-gaap	Severance Costs1 SeveranceCosts1	11700000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1109435000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1421374000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1784401000	USD

Files In Submission

Name	View Source	Status
0001628280-21-005660-index-headers.html	Edgar Link	pending
0001628280-21-005660-index.html	Edgar Link	pending
0001628280-21-005660.txt	Edgar Link	pending
0001628280-21-005660-xbrl.zip	Edgar Link	pending
dxm-20201231.htm	Edgar Link	pending
dxm-20201231.xsd	Edgar Link	pending
dxm-20201231_cal.xml	Edgar Link	unprocessable
dxm-20201231_def.xml	Edgar Link	unprocessable
dxm-20201231_g1.jpg	Edgar Link	pending
dxm-20201231_htm.xml	Edgar Link	completed
dxm-20201231_lab.xml	Edgar Link	unprocessable
dxm-20201231_pre.xml	Edgar Link	unprocessable
exhibit1016-202010xk.htm	Edgar Link	pending
exhibit211-202010xk.htm	Edgar Link	pending
exhibit231-202010xk.htm	Edgar Link	pending
exhibit311-202010xk.htm	Edgar Link	pending
exhibit312-202010xk.htm	Edgar Link	pending
exhibit321-202010xk.htm	Edgar Link	pending
exhibit322-202010xk.htm	Edgar Link	pending
exhibit41-202010xk.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_01.jpg	Edgar Link	pending
image_11.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thryv1.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THRY
Thryv Holdings Inc Stock $thry

2020 Q4 Form 10-K Financial Statement

#000162828021005660 Filed on March 25, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THRY Thryv Holdings Inc Stock $thry

2020 Q4 Form 10-K Financial Statement

#000162828021005660 Filed on March 25, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THRY
Thryv Holdings Inc Stock $thry